CG
Caroline Gaynor
Director at Amber Therapeutics
Ireland
Overview
Caroline Gaynor is a Partner at Lightstone Ventures in Ireland, with a background in Market Access and Regulatory Affairs in the Pharmaceutical Industry. She has held directorial roles at various companies including Amber Therapeutics, Volta Medical, and Carrick Therapeutics, and has invested in companies like Amber Therapeutics and Catamaran Bio at Series A stages.
Caroline Gaynor's career highlights include her roles as Director at multiple pharmaceutical and medical device companies, as well as her involvement in investing in early-stage companies like Amber Therapeutics and ProVerum Medical.
Work Experience
Director
2024 - Current
Director
2024
Director
2023
Director
2023
Partner
2023
Principal
2020 - 2023
Vice President
2016 - 2020
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics.
Council Member
2022
Director
2022
Director
2021
Director
2020
Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies.
Raised $42,000,000.00 from Astellas Venture Management, Lightstone Ventures, SV Health Investors, Takeda Ventures and Sofinnova Partners.
Director
2014 - 2020
Education
M.Sc
2008 - 2010
B.Sc(Pharm)
1998 - 2002